These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16457927)

  • 1. Current animal models of obsessive compulsive disorder: a critical review.
    Joel D
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):374-88. PubMed ID: 16457927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current animal models of obsessive compulsive disorder: an update.
    Albelda N; Joel D
    Neuroscience; 2012 Jun; 211():83-106. PubMed ID: 21925243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates.
    Albelda N; Joel D
    Neurosci Biobehav Rev; 2012 Jan; 36(1):47-63. PubMed ID: 21527287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The signal attenuation rat model of obsessive-compulsive disorder: a review.
    Joel D
    Psychopharmacology (Berl); 2006 Jul; 186(4):487-503. PubMed ID: 16718482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolutionary psychology of obsessive-compulsive disorder: the role of cognitive metarepresentation.
    Brüne M
    Perspect Biol Med; 2006; 49(3):317-29. PubMed ID: 16960303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.
    Wald R; Dodman N; Shuster L
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):191-7. PubMed ID: 19586234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.
    Zike I; Xu T; Hong N; Veenstra-VanderWeele J
    Neuroscience; 2017 Mar; 345():256-273. PubMed ID: 27646291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A review of the researches focusing on the heterogeneity of obsessive-compulsive disorder and its potential subtypes].
    Matsunaga H; Maebayashi K; Kiriike N
    Seishin Shinkeigaku Zasshi; 2008; 110(3):161-74. PubMed ID: 18464496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new explanatory model for obsessive-compulsive disorder].
    Visser HA; van Megen HJ; van Oppen P; van Balkom AJ
    Tijdschr Psychiatr; 2009; 51(4):227-37. PubMed ID: 19434577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advantage of obsessive-compulsive symptoms from the aspect of individual selection and group selection: an evolutionary psychological approach to obsessive-compulsive disorder].
    Gonda X; Jekkel E; Varga A; Miklósi M; Forintos DP
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):225-32. PubMed ID: 19213201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
    Gráf M
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
    Grados M; Prazak M; Saif A; Halls A
    Expert Opin Drug Discov; 2016; 11(1):27-43. PubMed ID: 26558411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Maudsley Obsessive-Compulsive Stimuli Set: validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder.
    Mataix-Cols D; Lawrence NS; Wooderson S; Speckens A; Phillips ML
    Psychiatry Res; 2009 Aug; 168(3):238-41. PubMed ID: 19515429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A proposed new target for deep brain stimulation in obsessive-compulsive disorder].
    Seijo-Zazo E; Seijo-Fernández F; Fernández-González F; Alvarez-Vega MA; Lozano-Aragoneses B
    Rev Neurol; 2007 Oct 1-15; 45(7):424-8. PubMed ID: 17918109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist.
    Geller DA; Doyle R; Shaw D; Mullin B; Coffey B; Petty C; Vivas F; Biederman J
    Compr Psychiatry; 2006; 47(3):234-40. PubMed ID: 16635654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Psycho-Behavioral Perspective on Modelling Obsessive-Compulsive Disorder (OCD) in Animals: The Role of Context.
    Wolmarans W; Stein DJ; Harvey BH
    Curr Med Chem; 2018; 25(41):5662-5689. PubMed ID: 28545371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing obsessive compulsive symptoms and cognitions on the internet: evidence for the comparability of paper and Internet administration.
    Coles ME; Cook LM; Blake TR
    Behav Res Ther; 2007 Sep; 45(9):2232-40. PubMed ID: 17306222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder.
    Cullen B; Brown CH; Riddle MA; Grados M; Bienvenu OJ; Hoehn-Saric R; Shugart YY; Liang KY; Samuels J; Nestadt G
    Depress Anxiety; 2007; 24(2):130-8. PubMed ID: 16892417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D; Doljansky J; Roz N; Rehavi M
    Neuroscience; 2005; 130(1):25-36. PubMed ID: 15561422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.